Who Paid My Doc
PoCP study in FSGS
Research payments
$1,602,821
Through program year 2025, $1,602,821 in research payments was reported against PoCP study in FSGS, across 230 payments.
- Paid by (largest first)
- Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $165,781 | 51 |
| 2024 | Research | $688,495 | 67 |
| 2023 | Research | $500,767 | 67 |
| 2022 | Research | $247,778 | 45 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Gaia Muallem Philadelphia, PA Named on 14 payments
- Vimal Derebail Chapel Hill, NC Named on 13 payments
- Rasheed Gbadegesin Durham, NC Named on 13 payments
- Juan Fernandez Miami, FL Named on 8 payments
- Chia-Shi Wang Atlanta, GA Named on 8 payments
- Isabelle Ayoub Columbus, OH Named on 6 payments
- Karthik Ramani Ann Arbor, MI Named on 6 payments
- Suneel Udani Hinsdale, IL Named on 6 payments
- Edouard Martin Lauderdale Lakes, FL Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.